We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Type II Diabetes plagues an estimated 9% of the U.S. population and gives rise to a variety of challenging medical complications. An estimated 28% of these individuals are living with the disease undiagnosed. The primary aim of this project was to use patient medical history to develop a machine learning algorithm to classify individuals with or without a(More)
BACKGROUND The addition of PCV (procarbazine, lomustine, vincristine) chemotherapy to radiotherapy (RT) for patients with high-risk (≥ 40 years old or sub-totally resected) low-grade glioma (LGG) results in an absolute median survival benefit of over 5 years. We evaluated the cost-effectiveness of this treatment strategy. METHODS A decision tree with an(More)
  • 1